This peptide blend combines CJC 1295 without DAC (5mg) and Ipamorelin (5mg) in a single vial for research applications involving growth hormone secretagogue synergy. CJC 1295 without DAC is a short-acting GHRH analog that stimulates GH release through the GHRH receptor, while Ipamorelin is a ghrelin receptor agonist that promotes GH secretion with minimal impact on appetite or cortisol. This synergistic formulation is studied for amplified GH pulse dynamics and somatotropic axis modulation in controlled laboratory settings. This high-purity blend is manufactured under strict quality control standards to ensure consistency and reliability for advanced research use only.
